sibutramine has been researched along with Psychoses in 7 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "This was a 12-week double-blind, placebo controlled, randomized trial of sibutramine for weight loss in obese clozapine-treated schizophrenia or schizoaffective disorder subjects." | 9.12 | A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. ( Borba, CP; Cather, C; Copeland, PM; Daley, TB; Evins, AE; Fan, X; Freudenreich, O; Goff, DC; Hayden, D; Henderson, DC; Nguyen, DD; Zhang, H, 2007) |
| "In this 24-week, open-label, flexible-dose, comparison trial, 46 outpatients with bipolar disorders who had a body mass index (BMI) > or =30 kg/m(2), or > or =27 kg/m(2) with obesity-related comorbidities, and psychotropic-associated weight gain were randomly assigned to receive sibutramine (n = 18; 5-15 mg/day) or topiramate (n = 28; 25-600 mg/day)." | 9.12 | A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. ( Altshuler, LL; Black, D; Denicoff, KD; Frye, MA; Hellemann, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, W; Post, RM; Suppes, T, 2007) |
| " This study examined the effectiveness of sibutramine, an approved weight loss agent, in overweight and obese subjects taking olanzapine for schizophrenia or schizoaffective disorder." | 9.11 | A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. ( Borba, CP; Cather, C; Copeland, PM; Daley, TB; Evins, AE; Freudenreich, O; Goff, DC; Hayden, D; Henderson, DC; Louie, PM; Nguyen, DD, 2005) |
| "This was a 12-week double-blind, placebo controlled, randomized trial of sibutramine for weight loss in obese clozapine-treated schizophrenia or schizoaffective disorder subjects." | 5.12 | A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. ( Borba, CP; Cather, C; Copeland, PM; Daley, TB; Evins, AE; Fan, X; Freudenreich, O; Goff, DC; Hayden, D; Henderson, DC; Nguyen, DD; Zhang, H, 2007) |
| "In this 24-week, open-label, flexible-dose, comparison trial, 46 outpatients with bipolar disorders who had a body mass index (BMI) > or =30 kg/m(2), or > or =27 kg/m(2) with obesity-related comorbidities, and psychotropic-associated weight gain were randomly assigned to receive sibutramine (n = 18; 5-15 mg/day) or topiramate (n = 28; 25-600 mg/day)." | 5.12 | A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. ( Altshuler, LL; Black, D; Denicoff, KD; Frye, MA; Hellemann, G; Keck, PE; Kupka, R; Leverich, GS; McElroy, SL; Mintz, J; Nolen, W; Post, RM; Suppes, T, 2007) |
| " This study examined the effectiveness of sibutramine, an approved weight loss agent, in overweight and obese subjects taking olanzapine for schizophrenia or schizoaffective disorder." | 5.11 | A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain. ( Borba, CP; Cather, C; Copeland, PM; Daley, TB; Evins, AE; Freudenreich, O; Goff, DC; Hayden, D; Henderson, DC; Louie, PM; Nguyen, DD, 2005) |
| "Sibutramine is a serotonin-norepinephrine-dopamine reuptake inhibitor, initially developed as a potential antidepressant and later approved for the management of obesity." | 1.72 | Suicide Attempt in a Patient with Sibutramine Associated Psychosis. ( Câmara Pestana, P; Ferreira, C; Ganança, L; Jerónimo, J; Santos, AL, 2022) |
| "A 39-year-old white woman started to take sibutramine to lose weight at a dosage of 10 mg/day." | 1.35 | Sibutramine-associated psychosis (case report). ( Gazdag, G; Szabó, Z, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Câmara Pestana, P | 1 |
| Ferreira, C | 1 |
| Santos, AL | 1 |
| Jerónimo, J | 1 |
| Ganança, L | 1 |
| Bertholee, D | 1 |
| ter Horst, PG | 1 |
| Wieringa, A | 1 |
| Smit, JP | 1 |
| Gazdag, G | 1 |
| Szabó, Z | 1 |
| Binbay, T | 1 |
| Henderson, DC | 2 |
| Copeland, PM | 2 |
| Daley, TB | 2 |
| Borba, CP | 2 |
| Cather, C | 2 |
| Nguyen, DD | 2 |
| Louie, PM | 1 |
| Evins, AE | 2 |
| Freudenreich, O | 2 |
| Hayden, D | 2 |
| Goff, DC | 2 |
| Fan, X | 1 |
| Zhang, H | 1 |
| McElroy, SL | 1 |
| Frye, MA | 1 |
| Altshuler, LL | 1 |
| Suppes, T | 1 |
| Hellemann, G | 1 |
| Black, D | 1 |
| Mintz, J | 1 |
| Kupka, R | 1 |
| Nolen, W | 1 |
| Leverich, GS | 1 |
| Denicoff, KD | 1 |
| Post, RM | 1 |
| Keck, PE | 1 |
3 trials available for sibutramine and Psychoses
| Article | Year |
|---|---|
A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
Topics: Adult; Antipsychotic Agents; Appetite Depressants; Behavior Therapy; Benzodiazepines; Combined Modal | 2005 |
A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.
Topics: Adult; Anthropometry; Antipsychotic Agents; Appetite Depressants; Blood Glucose; Body Mass Index; Bo | 2007 |
A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Appetite Depressants; Bipolar D | 2007 |
4 other studies available for sibutramine and Psychoses
| Article | Year |
|---|---|
Suicide Attempt in a Patient with Sibutramine Associated Psychosis.
Topics: Adult; Antipsychotic Agents; Cyclobutanes; Humans; Male; Psychotic Disorders; Suicide, Attempted | 2022 |
[Life-threatening psychosis caused by using sibutramine-contaminated weight-loss coffee].
Topics: Adult; Appetite Depressants; Brazil; Coffee; Cyclobutanes; Female; Food Contamination; Humans; Inter | 2013 |
Sibutramine-associated psychosis (case report).
Topics: Adult; Appetite Depressants; Cyclobutanes; Female; Humans; Psychotic Disorders; Risk Factors; Stress | 2008 |
[First-episode mania with psychotic features induced by over-the-counter diet aids containing sibutramine].
Topics: Appetite Depressants; Bipolar Disorder; Cyclobutanes; Humans; Hypnotics and Sedatives; Lorazepam; No | 2010 |